Engineers Gate Manager LP Harvard Bioscience Inc Transaction History

Engineers Gate Manager LP

  • $3.68 Billion
  • Q1 2024

A detailed history of Engineers Gate Manager LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 18,154 shares of HBIO stock, worth $50,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,154
Previous 21,173 14.26%
Holding current value
$50,649
Previous $113,000 32.74%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$4.02 - $5.39 $12,136 - $16,272
-3,019 Reduced 14.26%
18,154 $76,000
Q4 2023

Feb 14, 2024
SELL
$4.0 - $5.49 $33,852 - $46,461
-8,463 Reduced 28.56%
21,173 $113,000
Q3 2023

Nov 14, 2023
SELL
$4.0 - $5.82 $179,356 - $260,962
-44,839 Reduced 60.21%
29,636 $127,000
Q2 2023

Aug 14, 2023
BUY
$4.19 - $6.16 $249,413 - $366,680
59,526 Added 398.19%
74,475 $408,000
Q1 2023

May 15, 2023
SELL
$2.45 - $4.22 $8,491 - $14,626
-3,466 Reduced 18.82%
14,949 $62,000
Q4 2022

Feb 14, 2023
SELL
$2.12 - $2.86 $9,635 - $12,998
-4,545 Reduced 19.8%
18,415 $51,000
Q3 2022

Nov 14, 2022
SELL
$2.58 - $3.92 $294,834 - $447,965
-114,277 Reduced 83.27%
22,960 $59,000
Q2 2022

Aug 15, 2022
BUY
$3.28 - $6.42 $254,196 - $497,543
77,499 Added 129.73%
137,237 $494,000
Q1 2022

May 16, 2022
BUY
$5.16 - $7.14 $94,670 - $130,997
18,347 Added 44.33%
59,738 $371,000
Q4 2021

Feb 14, 2022
SELL
$6.37 - $8.18 $32,111 - $41,235
-5,041 Reduced 10.86%
41,391 $292,000
Q3 2021

Nov 15, 2021
SELL
$6.98 - $8.47 $177,061 - $214,858
-25,367 Reduced 35.33%
46,432 $324,000
Q2 2021

Aug 16, 2021
BUY
$5.44 - $8.4 $195,584 - $302,005
35,953 Added 100.3%
71,799 $598,000
Q1 2021

May 17, 2021
BUY
$3.91 - $6.99 $85,894 - $153,556
21,968 Added 158.29%
35,846 $196,000
Q4 2020

Feb 16, 2021
BUY
$3.0 - $4.5 $738 - $1,107
246 Added 1.8%
13,878 $60,000
Q3 2020

Nov 16, 2020
SELL
$2.75 - $4.2 $17,657 - $26,968
-6,421 Reduced 32.02%
13,632 $41,000
Q2 2020

Aug 17, 2020
BUY
$2.12 - $3.14 $42,512 - $62,966
20,053 New
20,053 $62,000
Q1 2020

May 15, 2020
SELL
$1.42 - $3.29 $21,072 - $48,823
-14,840 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$2.45 - $3.25 $19,634 - $26,045
-8,014 Reduced 35.07%
14,840 $45,000
Q3 2019

Nov 14, 2019
SELL
$1.59 - $3.47 $41,427 - $90,410
-26,055 Reduced 53.27%
22,854 $70,000
Q2 2019

Aug 14, 2019
BUY
$1.93 - $4.59 $63,715 - $151,529
33,013 Added 207.68%
48,909 $98,000
Q1 2019

May 15, 2019
SELL
$2.77 - $4.38 $1,335 - $2,111
-482 Reduced 2.94%
15,896 $69,000
Q4 2018

Feb 14, 2019
SELL
$3.03 - $5.0 $15,059 - $24,850
-4,970 Reduced 23.28%
16,378 $52,000
Q3 2018

Nov 01, 2018
BUY
$5.0 - $6.65 $106,740 - $141,964
21,348 New
21,348 $112,000

Others Institutions Holding HBIO

# of Institutions
92
Shares Held
32.8M
Call Options Held
4K
Put Options Held
2.2K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $116M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email